|
Clinical manifestation
|
Always positive PNC (n = 12 patients, 166 assessments)
|
Always negative PNC (n = 31 patients, 475 assessments)
|
Variable PNC (n = 26 patients, 459 assessments)
|
|---|
|
Glomerulonephritis
|
31.9 %
|
10.5 %a
|
6.5 %a
|
|
Arthritis
|
1.8 %b
|
16.6 %
|
6.1 %a,b
|
|
Mucocutaneous
|
24.7 %
|
21.3 %
|
13.9 %a,b
|
|
Alopecia
|
10.8 %
|
7.8 %
|
7.2 %
|
|
Hematologic
|
3.0 %c
|
1.1 %c
|
7.0 %b
|
|
SLEDAI-2K >1
|
57.8 %
|
48.8 %
|
44.7 %a,b
|
-
SLEDAI-2K Systemic Lupus Erythematosus Disease Activity Index 2000
-
aSignificant difference (p ≤ 0.05) compared with “Always positive PNC”
-
bSignificant difference (p ≤ 0.05) compared with “Always negative PNC”
-
cSignificant difference (p ≤ 0.05) compared with “Variable PNC”
- The 69 patients are grouped depending on the outcome of PNC assay (positive or negative) over time
